BRO vs IRD · P/E 30, rev $4.80B vs rev $11.0M
Brown & Brown Inc (BRO) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
Brown & Brown Inc (BRO) is a insurance brokers company listed on US.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Latest reported BRO revenue for 2024-12-31 was $4.80B. Net income was $1.00B. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
BRO currently screens at market cap $35.56B and trailing P/E 30.0. IRD currently screens at market cap $35.7M.
Not investment advice. Open the BRO and IRD stock pages for the full models.
Not investment advice.